Infectious Disease Diagnostics Market Size, Share Report, Analysis, Trends, Growth 2030

Table Of Content

Methodology

Free Analysis

Infectious disease is a type of disease caused by different microorganisms present in the surroundings. Infectious disease diagnostics includes different techniques, instruments, and consumables to diagnose the presence of microorganisms in the human body. The lack of sanitation and unhygienic conditions in the developing and under developing regions are the main causes for the increased prevalence of infectious disease. Due to the constant increase in the infectious diseases, most of the companies anticipate focusing on the development of in vitro diagnostics in the forecast period. Most of the infections are spread from bacteria and viruses. Bacterial infections and sexually transmitted diseases are the most common infections among others.

One of the major factors driving the growth of infectious disease diagnostics market over the forecast period is the increased prevalence of infectious disease. As per the UNAIDS report, there were around 36.7 million people in the world diagnosed with HIV/AIDS at the end of 2016 out of these, 2.1 million were children below 15 years of age. Increasing rate of infectious diseases has led to the increased adoption of molecular diagnostics over the forecast period. Moreover, increase in the government initiatives to prevent infectious disease and awareness programs are expected to promote the growth of infectious disease diagnostics market. Furthermore, market players are involved in the development of new and advanced technologies for the diagnosis of various infectious diseases at an early stage to provide better treatment. All the above factors are expected to support the growth of infectious disease diagnostics market over the forecast period. However, lack of awareness about advanced technologies and poor laboratory conditions are the major factors expected to inhibit the growth of infectious disease diagnostics market in the near future.

Infectious disease diagnostics market is segmented into product type, test type, application, and end-user. Based on product type, infectious disease diagnostics market is fragmented to consumables, instruments, and software & services. On the basis of test type, infectious disease diagnostics market is segmented into laboratory tests, an imaging test, and biopsies. Based on applications, infectious disease diagnostics market is classified into viral infection, bacterial infection, CNS infections, cardiovascular infection, GI infections, sexually transmitted disease, fungal infection, and others. Based on end users, infectious disease diagnostics market is segmented into diagnostic laboratories, contract research organization, academic and medical institutes, hospitals and surgical centers, ambulatory clinics, and home healthcare.

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa are the key regions of infectious disease diagnostics market. North America is expected to dominate the market in the forecast period which is closely followed by Europe in the near future. The Asia Pacific is the fastest growing region over the forecast period owing to the presence of developing economies. Latin America and the Middle East & Africa are expected to witness a considerable growth rate.

Some of the major players of infectious disease diagnostics market include Becton Dickinson & Company, Affymetrix, Abbott Laboratories, Cepheid Inc., BioMerieux, Hologic Inc., DiaSorin, Bio-Rad Laboratories Inc., Alere Inc., and Danaher Corporation, among others.